(Reuters) – Humanigen Inc and the U.S. Department of Defense have entered into a research and development agreement for its drug candidate for COVID-19, the company said on Friday.
(Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
(Reuters) – Humanigen Inc and the U.S. Department of Defense have entered into a research and development agreement for its drug candidate for COVID-19, the company said on Friday.
(Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
